ANDA 212615, held by Granules India. Pirfenidone.
As of Nov 14, 2026, ANDA 212615 (Pirfenidone), held by Granules India, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 12, 2021 | Original application | Tentative approval | None posted |
| Pirfenidone267MG · tablet;oral | Pirfenidone | None (tentative approval) |
| Pirfenidone801MG · tablet;oral | Pirfenidone | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters